News | Digital Pathology | April 09, 2019

Deep Lens Closes Series A Financing for Digital AI Pathology Platform

VIPER platform designed to aid with clinical trial recruitment at the time of diagnosis

Deep Lens Closes Series A Financing for Digital AI Pathology Platform

April 9, 2019 — Digital pathology company Deep Lens Inc. announced the closing of a $14 million Series A financing that will further expand the company’s artificial intelligence (AI) and platform product development activities. Deep Lens is focused on AI-driven digital pathology for clinical trial recruitment at the time of diagnosis.

The financing was led by Northpond Ventures. Existing investors Rev1 Ventures, Sierra Ventures and Tamarind-Hill Partners also participated in this round, which comes just three months after Deep Lens closed its VC-led seed equity round. Funding to date now totals $17.5 million.

The company’s flagship technology, called VIPER (Virtual Imaging for Pathology Education and Research), was originally developed for research purposes in Columbus, Ohio. There it was the de-facto platform for global oncology studies including The Cancer Genome Atlas Project (TCGA) and others, before being commercialized by Deep Lens. VIPER combines AI with advanced pathology workflows, while also facilitating peer-to-peer collaboration and patient identification for clinical trials. The ultimate aim is to provide users with fast and accurate information, along with expert consultation, for better patient care and advanced clinical research.

Patient recruitment for clinical trials remains a time-intensive, costly barrier to the execution of drug development programs. More than 14,000 oncology clinical trials are actively recruiting patients1, yet estimates put the rate of participation as low as 3 percent of potential trial candidates.2 Deep Lens’ VIPER platform enables the pathologist in clinical trial recruitment. By identifying eligible patients at the time of their diagnosis, much sooner than current methods, VIPER can help fast-track trial enrollment and potentially shorten the duration of the trial.

For more information: www.deeplens.ai

References

1. https://clinicaltrials.gov, Last accessed February 28, 2019

2. https://www.ncbi.nlm.nih.gov/books/NBK50895/

Related Content

Guerbet Signs Agreement With Icometrix for Exclusive Distribution of Icobrain
News | Neuro Imaging | October 16, 2019
Guerbet announced it has signed an exclusive agreement with Icometrix for the distribution in France, Italy and Brazil...
Subtle Medical Receives FDA 510(k) Clearance for AI-powered SubtleMR
Technology | Artificial Intelligence | October 16, 2019
Subtle Medical announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market SubtleMR. SubtleMR...
Feature | Artificial Intelligence | October 16, 2019 | By Siddharth (Sid) Shah
The period between November through February is pretty interesting for the field of medical imaging — two major confe
As the role of artificial intelligence continues to expand, many companies are making significant investments in this technology to offer solutions
Feature | Artificial Intelligence | October 09, 2019 | By Sharmistha Sarkar
Artificial intelligence (AI) is a technology
Sponsored Content | Whitepapers | Clinical Trials | October 09, 2019
A 2019 N G PX REPORT
RSNA Announces Intracranial Hemorrhage AI Challenge
News | Artificial Intelligence | October 08, 2019
The Radiological Society of North America (RSNA) recently launched its third annual artificial intelligence (AI)...
An illustration of radiology department analytics data showing GE Healthcare's business analytics software.
Feature | Radiology Business | October 08, 2019 | April Wilson
According to IBM, the world creates 2.5 quintillion bytes of data daily.
Applying radiology and cardiology PACS ergonomics expertise to help pathologists avoid repetitive stress injuries that can arise from adopting digital pathology
News | PACS Accessories | October 04, 2019
Applying radiology and cardiology PACS ergonomics expertise to help pathologists avoid repetitive stress injuries that...
Attendees of ASTRO 2019 walked the halls of McCormick Place in Chicago, Ill.

Attendees of ASTRO 2019 walked the halls of McCormick Place in Chicago, Ill.

Feature | ASTRO | October 03, 2019 | By Greg Freiherr
At the American Society for Radiation Oncology’s (ASTRO) 2019 a